mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
0.0049 |
0.9 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.0048 |
0.9 |
mRNA |
Platin |
CTRPv2 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |
mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
-0.0043 |
0.9 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0044 |
0.9 |
mRNA |
NSC23766 |
CTRPv2 |
pan-cancer |
AAC |
0.0043 |
0.9 |
mRNA |
Obatoclax Mesylate |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |